Cell Line ; Cell Movement/drug effects* ; Cell Movement/physiology ; Dose-Response Relationship, Drug ; Estrogens/pharmacology* ; Gene Expression Regulation/drug effects ; Gene Expression Regulation/genetics ; Gene Knockdown Techniques ; HMGB1 Protein/drug effects ; HMGB1 Protein/genetics ; HMGB1 Protein/physiology* ; Humans ; Keratinocytes/cytology ; Keratinocytes/drug effects* ; Keratinocytes/physiology ; Proteomics/methods* ; RNA, Small Interfering/genetics ; RNA, Small Interfering/pharmacology ; Signal Transduction/drug effects ; Signal Transduction/physiology ; Time Factors
Keywords
HMGB1 ; estrogen ; keratinocyte
Abstract
It is known that oestrogen influences skin wound healing by modulating the inflammatory response, cytokine expression and extracellular matrix deposition; accelerating re-epithelialization; and stimulating angiogenesis. To identify novel proteins associated with effects of oestrogen on keratinocyte, stable isotope labelling by amino acids in cell culture (SILAC)-based mass spectrometry was performed. Using SILAC, quantification of 1085 proteins was achieved. Among these proteins, 60 proteins were upregulated and 32 proteins were downregulated. Among significantly upregulated proteins, high-mobility group protein B1 (HMGB1) has been further evaluated for its role in the effect of oestrogen on keratinocytes. HMGB1 expression was strongly induced in oestrogen-treated keratinocytes in dose- and time-dependent manner. Further, HMGB1 was able to significantly accelerate the rate of HaCaT cell migration. To determine whether HMGB1 is involved in E2-induced HaCaT cell migration, cells were transfected with HMGB1 siRNA. Knockdown of HMGB1 blocked oestrogen-induced keratinocyte migration. Collectively, these experiments demonstrate that HMGB1 is a novel downstream mediator of oestrogen-stimulated keratinocyte migration.